glp-1 drugs pharmaceutical companies 2025 How Supply and Demand for Weight Loss is Playing Out in 2026 Novo cuts GLP-1 prices 70%,

This change will likely broaden access to GLP-1s, as approximately 20% of Americans receive benefits from Medicare

For these patients, insulin therapy with Tresiba may be the preferred option for glucose control

However, the cost and utilization of these powerful drugs require careful planning

This is how euglycemic DKA can develop ketones rise without dramatic hyperglycemia

Since the initial guidance, multiple retrospective cohort studies were reported comparing GLP-1RA users to nonusers for risks of postoperative respiratory complications, including aspiration and pneumonia, in various postoperative or postendoscopic settings [8-15]

The safety and tolerability of LY were monitored through vital signs, laboratory data, and adverse events (AEs)